Plerixafor with and without chemotherapy in poor mobilizers: Results from the German compassionate use program

Bone Marrow Transplantation

Volumn 46, Issue 8, 2011, Pages 1045-1052

  Hubel K ^a   Fresen, M M ^a   Salwender, H ^b   Basara, N ^c   Beier, R ^d   Theurich, S ^a   Christopeit, M ^e   Bogner, C ^f   Galm, O ^g   Hartwig, R ^h   Heits, F ⁱ   Lordick, F ^j   Rosler W ^k   Wehler, D ^l   Zander, A R ^m   Albert, M H ⁿ   Dressler, S ^o   Ebinger, M ^p   Frickhofen, N ^q   Hertenstein, B ^r   Kiehl, M ^s   Liebler, S ^t   Von Lilienfeld Toal, M ^u   Weidmann, E ^v   Weigelt, C ^w   Lange, F ^a   Kroger N ^m   more..

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b ASKLEPIOS KLINIK ALTONA   (Germany)

^c UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^g UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^h Katholisches Klinikum Duisburg   (Germany)

ⁱ Diakoniekrankenhaus Rotenburg   (Germany)

^j KLINIKUM BRAUNSCHWEIG   (Germany)

^k UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^l JOHANNES GUTENBERG UNIVERSITY   (Germany)

^m UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

ⁿ LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^o KLINIKUM NÜRNBERG   (Germany)

^p UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^q DR HORST SCHMIDT KLINIKEN   (Germany)

^r KLINIKUM BREMEN MITTE   (Germany)

^s Klinikum Frankfurt Oder   (Germany)

^t UNIVERSITY HOSPITAL MARBURG   (Germany)

^u UNIVERSITY OF BONN   (Germany)

^v KRANKENHAUS NORDWEST   (Germany)

^w HEINRICH HEINE UNIVERSITY   (Germany)

more..

Author keywords

plerixafor; poor mobilizers; stem cell mobilization

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; PLERIXAFOR;

ABDOMINAL DISTENSION; ADULT; AGED; APHERESIS; ARTICLE; BLOATING; BONE PAIN; CANCER COMBINATION CHEMOTHERAPY; CARDIOTOXICITY; CD34 SELECTION; CHILD; CLINICAL EVALUATION; COMPASSIONATE USE; DEFECATION; DIARRHEA; DISEASE DURATION; DISEASE SEVERITY; DRUG RESPONSE; DRUG SAFETY; ENGRAFTMENT; EVENING DOSAGE; FACIAL NERVE PARALYSIS; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; GERMANY; GRAFT REJECTION; HEADACHE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; INJECTION SITE ERYTHEMA; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORNING DOSAGE; MULTICENTER STUDY; MULTIPLE MYELOMA; NAUSEA AND VOMITING; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; SIDE EFFECT; STEM CELL MOBILIZATION; TREATMENT DURATION; VOMITING; XEROSTOMIA;

ADOLESCENT; ADULT; AGED; BLOOD COMPONENT REMOVAL; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; COMPASSIONATE USE TRIALS; FEMALE; GERMANY; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HETEROCYCLIC COMPOUNDS; HODGKIN DISEASE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MULTIPLE MYELOMA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80051675365     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2010.249     Document Type: Article

References (38)

1. Demirer T, Bensinger WI, Buckner CD. Peripheral blood stem cell mobilization for high-dose chemotherapy. J Hematother 1999; 8: 103-113. (Pubitemid 29232633)
2. Bensinger W, Appelbaum F, Rowley S, Storb R, Sanders J, Lilleby K et al. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 1995; 13: 2547-2555.
3. Pusic I, Jiang SY, Landua S, Uy GL, Rettig MP, Cashen AF et al. Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation. Biol Blood Marrow Transplant 2008; 14: 1045-1056.
4. Villalon L, Odriozola J, Larana JG, Zamora C, Perez de Oteyza J, Jodra MH et al. Autologous peripheral blood progenitor cell transplantation with <2 x 10 CD34(+)/kg: an analysis of variables concerning mobilisation and engraftment. Hematol J 2000; 1: 374-381.
5. Kessinger A, Sharp JG. The whys and hows of hematopoietic progenitor and stem cell mobilization. Bone Marrow Transplant 2003; 31: 319-329. (Pubitemid 36410677)
6. Koenigsmann M, Jentsch-Ullrich K, Mohren M, Becker E, Heim M, Franke A. The role of diagnosis in patients failing peripheral blood progenitor cell mobilization. Transfusion 2004; 44: 777-784. (Pubitemid 38608258)
7. Pastore D, Specchia G, Mestice A, Liso A, Pannunzio A, Carluccio P et al. Good and poor CD34+ cell mobilization in acute leukemia: analysis of factors affecting the yield of progenitor cells. Bone Marrow Transplant 2004; 33: 1083-1087. (Pubitemid 38786497)
8. Moog R. Management strategies for poor peripheral blood stem cell mobilization. Transfus Apher Sci 2008; 38: 229-236.
9. Mendrone Jr A, Arrais CA, Saboya R, Chamone Dde A, Dulley FL. Factors affecting hematopoietic progenitor cell mobilization: an analysis of 307 patients. Transfus Apher Sci 2008; 39: 187-192.
10. Pavone V, Gaudio F, Console G, Vitolo U, Iacopino P, Guarini A et al. Poor mobilization is an independent prognostic factor in patients with malignant lymphomas treated by peripheral blood stem cell transplantation. Bone Marrow Transplant 2006; 37: 719-724.
11. Kuittinen T, Nousiainen T, Halonen P, Mahlamaki E, Jantunen E. Prediction of mobilisation failure in patients with non-Hodgkin'lymphoma. Bone Marrow Transplant 2004; 33: 907-912. (Pubitemid 38660123)
12. Akhtar S, Weshi AE, Rahal M, Khafaga Y, Tbakhi A, Humaidan H et al. Factors affecting autologous peripheral blood stem cell collection in patients with relapsed or refractory diffuse large cell lymphoma and Hodgkin lympho-ma: a single institution result of 168 patients. Leuk Lymphoma 2008; 49: 769-778. (Pubitemid 351517224)
13. Wuchter P, Ran D, Bruckner T, Schmitt T, Witzens-Harig M, Neben K et al. Poor mobilization of hematopoietic stem cells-definitions, incidence, risk factors, and impact on outcome of autologous transplantation. Biol Blood Marrow Transplant 2010; 16: 490-499.
14. Nagasawa T. A chemokine, SDF-1/PBSF, and its receptor, CXC chemokine receptor 4, as mediators of hematopoiesis. Int J Hematol 2000; 72: 408-411.
15. Lee Y, Gotoh A, Kwon HJ, You M, Kohli L, Mantel C et al. Enhancement of intracellular signaling associated with hematopoietic progenitor cell survival in response to SDF-1/CXCL12 in synergy with other cytokines. Blood 2002; 99: 4307-4317. (Pubitemid 34627195)
16. Mohle R, Bautz F, Rafii S, Moore MA, Brugger W, Kanz L. The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. Blood 1998; 91: 4523-4530. (Pubitemid 28270300)
17. Gerlach LO, Skerlj RT, Bridger GJ, Schwartz TW. Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor. J Biol Chem 2001; 276: 14153-14160.
18. Hubel K, Liles WC, Broxmeyer HE, Rodger E, Wood B, Cooper S et al. Leukocytosis and mobilization of CD34+ hematopoietic progenitor cells by AMD3100, a CXCR4 antagonist. Support Cancer Ther 2004; 1: 165-172.
19. Hendrix CW, Collier AC, Lederman MM, Schols D, Pollard RB, Brown S et al. Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection. J Acquir Immune Defic Syndr 2004; 37: 1253-1262. (Pubitemid 39281506)
20. Liles WC, Rodger E, Broxmeyer HE, Dehner C, Badel K, Calandra G et al. Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with granulocyte-colony-stimulating factor by single-dose administration of AMD3100, a CXCR4 antagonist. Transfusion 2005; 45: 295-300. (Pubitemid 40389423)
21. Flomenberg N, Devine SM, Dipersio JF, Liesveld JL, McCarty JM, Rowley SD et al. The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone. Blood 2005; 106: 1867-1874. (Pubitemid 41208607)
22. Tricot G, Cottler-Fox MH, Calandra G. Safety and efficacy assessment of plerixafor in patients with multiple myeloma proven or predicted to be poor mobilizers, including assessment of tumor cell mobilization. Bone Marrow Transplant 2010; 45: 63-68.
23. Duarte RF, Shaw BE, Marin P, Kottaridis P, Ortiz M, Morante C et al. Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lympho-ma patients failing previous mobilization attempts: EU compassionate use data. Bone Marrow Transplant (e-pub ahead of print 22 March 2010; doi:10.1038/bmt.2010.54).
24. Calandra G, McCarty J, McGuirk J, Tricot G, Crocker SA, Badel K et al. AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data. Bone Marrow Transplant 2008; 41: 331-338. (Pubitemid 351330727)
25. Tricot G, Cottler-Fox MH, Calandra G. Safety and efficacy assessment of plerixafor in patients with multiple myeloma proven or predicted to be poor mobilizers, including assessment of tumor cell mobilization. Bone Marrow Transplant 2010; 45: 63-68.
26. Micallef IN, Stiff PJ, DiPersio JF, Maziarz RT, McCarty JM, Bridger G et al. Successful stem cell remobilization using plerixafor (mozobil) plus granulocyte colony-stimulating factor in patients with non-hodgkin lymphoma: results from the plerixafor NHL phase 3 study rescue protocol. Biol Blood Marrow Transplant 2009; 15: 1578-1586.
27. Fowler CJ, Dunn A, Hayes-Lattin B, Hansen K, Hansen L, Lanier K et al. Rescue from failed growth factor and/or chemotherapy HSC mobilization with G-CSF and plerixafor (AMD3100): an institutional experience. Bone Marrow Transplant 2009; 43: 909-917.
28. Flomenberg N, Comenzo RL, Badel K, Calandra G. Plerixafor (Mozobil) alone to mobilize hematopoietic stem cells from multiple myeloma patients for autologous transplantation. Biol Blood Marrow Transplant 2010; 16: 695-700.
29. DiPersio JF, Stadtmauer EA, Nademanee A, Micallef IN, Stiff PJ, Kaufman JL et al. Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for auto-logous stem cell transplantation in patients with multiple myeloma. Blood 2009; 113: 5720-5726.
30. DiPersio JF, Micallef IN, Stiff PJ, Bolwell BJ, Maziarz RT, Jacobsen E et al. Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granu-locyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma. J Clin Oncol 2009; 27: 4767-4773.
31. Flomenberg N, DiPersio J, Calandra G. Role of CXCR4 chemokine receptor blockade using AMD3100 for mobilization of autologous hematopoietic progenitor cells. Acta Haematol 2005; 114: 198-205. (Pubitemid 41567002)
32. Cashen A, Lopez S, Gao F, Calandra G, MacFarland R, Badel K et al. A phase II study of plerixafor (AMD3100) plus G-CSF for autologous hematopoietic progenitor cell mobilization in patients with Hodgkin lymphoma. Biol Blood Marrow Transplant 2008; 14: 1253-1261.
33. Hendrix CW, Flexner C, MacFarland RT, Giandomenico C, Fuchs EJ, Redpath E et al. Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers. Antimicrob Agents Chemother 2000; 44: 1667-1673. (Pubitemid 30340812)
34. Liles WC, Broxmeyer HE, Rodger E, Wood B, Hubel K, Cooper S et al. Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. Blood 2003; 102: 2728-2730. (Pubitemid 37248839)
35. Cashen AF, Lazarus HM, Devine SM. Mobilizing stem cells from normal donors: is it possible to improve upon G-CSF? Bone Marrow Transplant 2007; 39: 577-588. (Pubitemid 46729051)
36. Stewart DA, Smith C, MacFarland R, Calandra G. Pharma-cokinetics and pharmacodynamics of plerixafor in patients with non-Hodgkin lymphoma and multiple myeloma. Biol Blood Marrow Transplant 2009; 15: 39-46.
37. Hicks ML, Lonial S, Langston A, Flowers C, Roback JD, Smith KJ et al. Optimizing the timing of chemotherapy for mobilizing autologous blood hematopoietic progenitor cells. Transfusion 2007; 47: 629-635. (Pubitemid 46449623)
38. Toledano H, Yahel A, Cohen IJ, Yaniv I, Stein J. Successful mobilization, harvest and transplant of peripheral blood stem cells using AMD3100 and G-CSF following high dose craniospinal irradiation for medullo-blastoma in a young child. Pediatr Blood Cancer 2010; 54: 613-615.